Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.46126398 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.46126398 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.04496532 |
4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.95323063 |
5 | positive regulation of histone deacetylation (GO:0031065) | 4.87881405 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.86643903 |
7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.35700150 |
8 | negative regulation of cell killing (GO:0031342) | 4.27607155 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.27607155 |
10 | positive thymic T cell selection (GO:0045059) | 4.15546238 |
11 | natural killer cell differentiation (GO:0001779) | 3.62339105 |
12 | thymic T cell selection (GO:0045061) | 3.60355051 |
13 | response to peptidoglycan (GO:0032494) | 3.57125251 |
14 | negative T cell selection (GO:0043383) | 3.54107747 |
15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.52879240 |
16 | modulation by symbiont of host defense response (GO:0052031) | 3.52879240 |
17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.52879240 |
18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.52879240 |
19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.52879240 |
20 | modulation by symbiont of host immune response (GO:0052553) | 3.52879240 |
21 | negative thymic T cell selection (GO:0045060) | 3.48427944 |
22 | positive T cell selection (GO:0043368) | 3.45313926 |
23 | positive regulation of protein deacetylation (GO:0090312) | 3.39472333 |
24 | response to muramyl dipeptide (GO:0032495) | 3.36740189 |
25 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.33890604 |
26 | T cell selection (GO:0045058) | 3.32229858 |
27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.31911352 |
28 | negative regulation of cell size (GO:0045792) | 3.26510912 |
29 | leukocyte aggregation (GO:0070486) | 3.23915666 |
30 | germinal center formation (GO:0002467) | 3.22392630 |
31 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.21398646 |
32 | modulation by virus of host process (GO:0019054) | 3.19815808 |
33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.19630155 |
34 | positive regulation of B cell differentiation (GO:0045579) | 3.18483885 |
35 | modulation by symbiont of host cellular process (GO:0044068) | 3.13718369 |
36 | NIK/NF-kappaB signaling (GO:0038061) | 3.11421128 |
37 | protein localization to endosome (GO:0036010) | 3.07527852 |
38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07359943 |
39 | regulation of cholesterol homeostasis (GO:2000188) | 3.03532313 |
40 | regulation of histone H3-K27 methylation (GO:0061085) | 3.02244940 |
41 | peptidyl-lysine dimethylation (GO:0018027) | 3.01758469 |
42 | regulation of leukocyte degranulation (GO:0043300) | 2.98812408 |
43 | detection of bacterium (GO:0016045) | 2.97734336 |
44 | B cell receptor signaling pathway (GO:0050853) | 2.95177665 |
45 | pinocytosis (GO:0006907) | 2.92294824 |
46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91634577 |
47 | detection of other organism (GO:0098543) | 2.90416795 |
48 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.89885798 |
49 | tolerance induction (GO:0002507) | 2.89483458 |
50 | neutrophil activation involved in immune response (GO:0002283) | 2.88453249 |
51 | response to interleukin-15 (GO:0070672) | 2.87432712 |
52 | positive regulation of Rap GTPase activity (GO:0032854) | 2.85915578 |
53 | apoptotic process involved in morphogenesis (GO:0060561) | 2.83720495 |
54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83272753 |
55 | regulation of ARF GTPase activity (GO:0032312) | 2.82676625 |
56 | activation of Rac GTPase activity (GO:0032863) | 2.80169092 |
57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79169601 |
58 | macrophage activation involved in immune response (GO:0002281) | 2.78647567 |
59 | maternal placenta development (GO:0001893) | 2.75618311 |
60 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.74983992 |
61 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74714177 |
62 | response to laminar fluid shear stress (GO:0034616) | 2.74449599 |
63 | regulation of translational termination (GO:0006449) | 2.74112053 |
64 | regulation of defense response to virus by virus (GO:0050690) | 2.72760604 |
65 | Peyers patch development (GO:0048541) | 2.71138369 |
66 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.71138369 |
67 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.67312791 |
68 | regulation of mast cell degranulation (GO:0043304) | 2.66984124 |
69 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.66101606 |
70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65704652 |
71 | growth hormone receptor signaling pathway (GO:0060396) | 2.63796148 |
72 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.63633681 |
73 | regulation of ARF protein signal transduction (GO:0032012) | 2.62421628 |
74 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.62053991 |
75 | regulation of translational fidelity (GO:0006450) | 2.61842706 |
76 | regulation of superoxide anion generation (GO:0032928) | 2.61802116 |
77 | regulation of B cell differentiation (GO:0045577) | 2.61261274 |
78 | negative regulation of phagocytosis (GO:0050765) | 2.58950041 |
79 | cortical actin cytoskeleton organization (GO:0030866) | 2.58736967 |
80 | embryonic process involved in female pregnancy (GO:0060136) | 2.58639879 |
81 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.56913183 |
82 | cellular extravasation (GO:0045123) | 2.56005315 |
83 | mannose metabolic process (GO:0006013) | 2.55904666 |
84 | pre-miRNA processing (GO:0031054) | 2.55723293 |
85 | histone H3-K36 demethylation (GO:0070544) | 2.55533010 |
86 | sodium ion export (GO:0071436) | 2.54491786 |
87 | activation of JUN kinase activity (GO:0007257) | 2.54381790 |
88 | regulation of early endosome to late endosome transport (GO:2000641) | 2.54042810 |
89 | immunoglobulin mediated immune response (GO:0016064) | 2.53360779 |
90 | regulation of necroptotic process (GO:0060544) | 2.53123232 |
91 | pentose-phosphate shunt (GO:0006098) | 2.52918164 |
92 | alpha-linolenic acid metabolic process (GO:0036109) | 2.51357847 |
93 | receptor catabolic process (GO:0032801) | 2.51092916 |
94 | regulation of cholesterol storage (GO:0010885) | 2.50729957 |
95 | mRNA stabilization (GO:0048255) | 2.50607189 |
96 | RNA stabilization (GO:0043489) | 2.50607189 |
97 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.50148857 |
98 | cellular response to interleukin-4 (GO:0071353) | 2.49669563 |
99 | cellular response to virus (GO:0098586) | 2.49433337 |
100 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.49181872 |
101 | T cell costimulation (GO:0031295) | 2.49085104 |
102 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.48981670 |
103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.48524996 |
104 | positive regulation of lamellipodium assembly (GO:0010592) | 2.46909481 |
105 | response to host (GO:0075136) | 2.45731579 |
106 | response to host defenses (GO:0052200) | 2.45731579 |
107 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45731579 |
108 | negative regulation of viral release from host cell (GO:1902187) | 2.45276035 |
109 | positive regulation of granulocyte differentiation (GO:0030854) | 2.44903177 |
110 | germ cell migration (GO:0008354) | 2.44452425 |
111 | B cell homeostasis (GO:0001782) | 2.43444096 |
112 | negative regulation of necroptotic process (GO:0060546) | 2.42122227 |
113 | cellular hyperosmotic response (GO:0071474) | 2.41984131 |
114 | Golgi transport vesicle coating (GO:0048200) | 2.41954749 |
115 | COPI coating of Golgi vesicle (GO:0048205) | 2.41954749 |
116 | NLS-bearing protein import into nucleus (GO:0006607) | 2.41257181 |
117 | regulation of histone deacetylation (GO:0031063) | 2.41155753 |
118 | lymphocyte costimulation (GO:0031294) | 2.40663139 |
119 | regulation of regulated secretory pathway (GO:1903305) | 2.40031432 |
120 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.37696594 |
121 | negative regulation of histone methylation (GO:0031061) | 2.37049262 |
122 | response to type I interferon (GO:0034340) | 2.36616631 |
123 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.35808193 |
124 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.35651335 |
125 | cellular response to type I interferon (GO:0071357) | 2.35362095 |
126 | type I interferon signaling pathway (GO:0060337) | 2.35362095 |
127 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.35298350 |
128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.35147853 |
129 | response to host immune response (GO:0052572) | 2.35147853 |
130 | negative regulation of lipid transport (GO:0032369) | 2.31986552 |
131 | positive regulation of nuclease activity (GO:0032075) | 2.31796420 |
132 | valine metabolic process (GO:0006573) | 2.30826784 |
133 | T cell receptor signaling pathway (GO:0050852) | 2.28945400 |
134 | adaptation of signaling pathway (GO:0023058) | 2.27756888 |
135 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.27007015 |
136 | regulation of Rap GTPase activity (GO:0032317) | 2.26562810 |
137 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.24687212 |
138 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.23324626 |
139 | megakaryocyte development (GO:0035855) | 2.23216856 |
140 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.23003090 |
141 | regulation of erythrocyte differentiation (GO:0045646) | 2.22233933 |
142 | 2-oxoglutarate metabolic process (GO:0006103) | 2.22095602 |
143 | positive regulation of lamellipodium organization (GO:1902745) | 2.21325892 |
144 | cellular response to growth hormone stimulus (GO:0071378) | 2.21135541 |
145 | dosage compensation (GO:0007549) | 2.21082229 |
146 | T cell migration (GO:0072678) | 2.20516160 |
147 | adherens junction assembly (GO:0034333) | 2.19802514 |
148 | oxaloacetate metabolic process (GO:0006107) | 2.19623029 |
149 | stress fiber assembly (GO:0043149) | 2.19129984 |
150 | peptidyl-threonine modification (GO:0018210) | 2.18746402 |
151 | signal complex assembly (GO:0007172) | 2.18550182 |
152 | cell-substrate adherens junction assembly (GO:0007045) | 2.18384250 |
153 | focal adhesion assembly (GO:0048041) | 2.18384250 |
154 | heterochromatin organization (GO:0070828) | 2.18086289 |
155 | regulation of extracellular matrix disassembly (GO:0010715) | 2.17930631 |
156 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.16825441 |
157 | negative regulation of sterol transport (GO:0032372) | 2.16008240 |
158 | negative regulation of cholesterol transport (GO:0032375) | 2.16008240 |
159 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.15249665 |
160 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.15051790 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MYC_22102868_ChIP-Seq_BL_Human | 4.03807921 |
2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.75925253 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49812747 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26098339 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.01441924 |
6 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.86967896 |
7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.82877976 |
8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.71667686 |
9 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.57833461 |
10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.55852162 |
11 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.46470190 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.43186312 |
13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.36270120 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.33283099 |
15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24019561 |
16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.12078268 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11671491 |
18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06356295 |
19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03002517 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01165840 |
21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00791797 |
22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.00144864 |
23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99583849 |
24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.98546056 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.97195266 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90423065 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89457905 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84713610 |
29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82061782 |
30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81374332 |
31 | MYB_26560356_Chip-Seq_TH2_Human | 1.80897635 |
32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79092663 |
33 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.79053901 |
34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72302396 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72112491 |
36 | MYB_26560356_Chip-Seq_TH1_Human | 1.71776101 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70782798 |
38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67835690 |
39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66075763 |
40 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.63201963 |
41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62001257 |
42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57912676 |
43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56178154 |
44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55370352 |
45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53272786 |
46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51061462 |
47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50498398 |
48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50144244 |
49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49379151 |
50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48123935 |
51 | MAF_26560356_Chip-Seq_TH2_Human | 1.48051990 |
52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47316773 |
53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45673317 |
54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43694470 |
55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41239503 |
56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40953969 |
57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.40657814 |
58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.40091547 |
59 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.39321260 |
60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38697417 |
61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37995446 |
62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32925288 |
63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31829247 |
64 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.31753697 |
65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29726807 |
66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28574200 |
67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28356113 |
68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27451575 |
69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26345265 |
70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26141131 |
71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25176834 |
72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24888424 |
73 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24536748 |
74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24249550 |
75 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.21539437 |
76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21218147 |
77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21052517 |
78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19789137 |
79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18192805 |
80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16848132 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16297724 |
82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16281899 |
83 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16189669 |
84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15869677 |
85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15651887 |
86 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15379435 |
87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15330174 |
88 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15120817 |
89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14362392 |
90 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14170047 |
91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10452703 |
92 | P68_20966046_ChIP-Seq_HELA_Human | 1.10447169 |
93 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10443902 |
94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10361112 |
95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09233200 |
96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09094824 |
97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08050116 |
98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07616409 |
99 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06681334 |
100 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06528790 |
101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06461722 |
102 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06393316 |
103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06356293 |
104 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06170267 |
105 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.06088652 |
106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06018945 |
107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05919844 |
108 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05381667 |
109 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05309460 |
110 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05095826 |
111 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05070278 |
112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04912917 |
113 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04767983 |
114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04052269 |
115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03291008 |
116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02650706 |
117 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02261608 |
118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01321447 |
119 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00946578 |
120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00615399 |
121 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99957926 |
122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98499462 |
123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97491008 |
124 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.97331454 |
125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97260264 |
126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97014650 |
127 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96406972 |
128 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96221240 |
129 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94495338 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003300_gastrointestinal_ulcer | 3.84907344 |
2 | MP0003303_peritoneal_inflammation | 3.46384983 |
3 | MP0003705_abnormal_hypodermis_morpholog | 3.06158972 |
4 | MP0005451_abnormal_body_composition | 2.83938460 |
5 | MP0009278_abnormal_bone_marrow | 2.62927398 |
6 | MP0008961_abnormal_basal_metabolism | 2.45088503 |
7 | MP0000685_abnormal_immune_system | 2.43852952 |
8 | MP0010352_gastrointestinal_tract_polyps | 2.43629991 |
9 | MP0005360_urolithiasis | 2.29801801 |
10 | MP0005076_abnormal_cell_differentiation | 2.28646325 |
11 | MP0008260_abnormal_autophagy | 2.13403324 |
12 | MP0009840_abnormal_foam_cell | 2.13102826 |
13 | MP0004510_myositis | 2.04632842 |
14 | MP0001800_abnormal_humoral_immune | 2.02700561 |
15 | MP0003763_abnormal_thymus_physiology | 2.02431422 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.02313431 |
17 | MP0010234_abnormal_vibrissa_follicle | 1.97703389 |
18 | MP0001790_abnormal_immune_system | 1.93956553 |
19 | MP0005387_immune_system_phenotype | 1.93956553 |
20 | MP0005464_abnormal_platelet_physiology | 1.88599052 |
21 | MP0001835_abnormal_antigen_presentation | 1.85990363 |
22 | MP0002396_abnormal_hematopoietic_system | 1.84353238 |
23 | MP0003436_decreased_susceptibility_to | 1.84351031 |
24 | MP0004947_skin_inflammation | 1.82886156 |
25 | MP0004808_abnormal_hematopoietic_stem | 1.81304559 |
26 | MP0002398_abnormal_bone_marrow | 1.80808892 |
27 | MP0002166_altered_tumor_susceptibility | 1.79145003 |
28 | MP0002139_abnormal_hepatobiliary_system | 1.78267344 |
29 | MP0010307_abnormal_tumor_latency | 1.68660339 |
30 | MP0005397_hematopoietic_system_phenotyp | 1.67494023 |
31 | MP0001545_abnormal_hematopoietic_system | 1.67494023 |
32 | MP0000858_altered_metastatic_potential | 1.66728892 |
33 | MP0000703_abnormal_thymus_morphology | 1.60235842 |
34 | MP0002452_abnormal_antigen_presenting | 1.59488696 |
35 | MP0003566_abnormal_cell_adhesion | 1.57781502 |
36 | MP0010155_abnormal_intestine_physiology | 1.55476017 |
37 | MP0002420_abnormal_adaptive_immunity | 1.53402329 |
38 | MP0004185_abnormal_adipocyte_glucose | 1.52585313 |
39 | MP0001819_abnormal_immune_cell | 1.51767203 |
40 | MP0002722_abnormal_immune_system | 1.51625119 |
41 | MP0003252_abnormal_bile_duct | 1.51443412 |
42 | MP0002723_abnormal_immune_serum | 1.51045404 |
43 | MP0000689_abnormal_spleen_morphology | 1.49253190 |
44 | MP0003866_abnormal_defecation | 1.48985302 |
45 | MP0000716_abnormal_immune_system | 1.48356670 |
46 | MP0003172_abnormal_lysosome_physiology | 1.44929893 |
47 | MP0005000_abnormal_immune_tolerance | 1.42674178 |
48 | MP0001873_stomach_inflammation | 1.41062691 |
49 | MP0005671_abnormal_response_to | 1.36657649 |
50 | MP0004130_abnormal_muscle_cell | 1.36370571 |
51 | MP0000609_abnormal_liver_physiology | 1.36052564 |
52 | MP0005365_abnormal_bile_salt | 1.35077272 |
53 | MP0004381_abnormal_hair_follicle | 1.34950422 |
54 | MP0002877_abnormal_melanocyte_morpholog | 1.33509370 |
55 | MP0002405_respiratory_system_inflammati | 1.28174673 |
56 | MP0005025_abnormal_response_to | 1.28166436 |
57 | MP0010329_abnormal_lipoprotein_level | 1.28068971 |
58 | MP0002429_abnormal_blood_cell | 1.27340509 |
59 | MP0002148_abnormal_hypersensitivity_rea | 1.26377253 |
60 | MP0005085_abnormal_gallbladder_physiolo | 1.26349536 |
61 | MP0003045_fibrosis | 1.26080398 |
62 | MP0005409_darkened_coat_color | 1.21232332 |
63 | MP0003724_increased_susceptibility_to | 1.20947077 |
64 | MP0006082_CNS_inflammation | 1.20724522 |
65 | MP0002998_abnormal_bone_remodeling | 1.17869435 |
66 | MP0005058_abnormal_lysosome_morphology | 1.16756041 |
67 | MP0002419_abnormal_innate_immunity | 1.16466971 |
68 | MP0000678_abnormal_parathyroid_gland | 1.16118432 |
69 | MP0001845_abnormal_inflammatory_respons | 1.15019662 |
70 | MP0002006_tumorigenesis | 1.13911456 |
71 | MP0005666_abnormal_adipose_tissue | 1.09526605 |
72 | MP0001348_abnormal_lacrimal_gland | 1.09085973 |
73 | MP0000604_amyloidosis | 1.05878701 |
74 | MP0000569_abnormal_digit_pigmentation | 1.05721662 |
75 | MP0003075_altered_response_to | 1.04747695 |
76 | MP0001851_eye_inflammation | 1.04078254 |
77 | MP0005083_abnormal_biliary_tract | 1.03930856 |
78 | MP0001849_ear_inflammation | 1.03100734 |
79 | MP0000465_gastrointestinal_hemorrhage | 1.01876910 |
80 | MP0004264_abnormal_extraembryonic_tissu | 1.01688102 |
81 | MP0009333_abnormal_splenocyte_physiolog | 0.97843370 |
82 | MP0005621_abnormal_cell_physiology | 0.97733764 |
83 | MP0003828_pulmonary_edema | 0.96883769 |
84 | MP0005375_adipose_tissue_phenotype | 0.95201757 |
85 | MP0002796_impaired_skin_barrier | 0.95025543 |
86 | MP0005310_abnormal_salivary_gland | 0.94429166 |
87 | MP0002132_abnormal_respiratory_system | 0.93496522 |
88 | MP0003111_abnormal_nucleus_morphology | 0.93171507 |
89 | MP0005023_abnormal_wound_healing | 0.92924830 |
90 | MP0010630_abnormal_cardiac_muscle | 0.91058765 |
91 | MP0003183_abnormal_peptide_metabolism | 0.90211620 |
92 | MP0003329_amyloid_beta_deposits | 0.89783308 |
93 | MP0000598_abnormal_liver_morphology | 0.89105532 |
94 | MP0003091_abnormal_cell_migration | 0.89041549 |
95 | MP0005166_decreased_susceptibility_to | 0.87331913 |
96 | MP0004858_abnormal_nervous_system | 0.85791872 |
97 | MP0002138_abnormal_hepatobiliary_system | 0.82986782 |
98 | MP0008469_abnormal_protein_level | 0.82826767 |
99 | MP0009785_altered_susceptibility_to | 0.82666895 |
100 | MP0002909_abnormal_adrenal_gland | 0.81428036 |
101 | MP0008874_decreased_physiological_sensi | 0.81398861 |
102 | MP0005501_abnormal_skin_physiology | 0.80736207 |
103 | MP0002019_abnormal_tumor_incidence | 0.80468868 |
104 | MP0000733_abnormal_muscle_development | 0.80109442 |
105 | MP0001730_embryonic_growth_arrest | 0.79503932 |
106 | MP0009931_abnormal_skin_appearance | 0.79028744 |
107 | MP0003453_abnormal_keratinocyte_physiol | 0.78031397 |
108 | MP0003656_abnormal_erythrocyte_physiolo | 0.77636348 |
109 | MP0002928_abnormal_bile_duct | 0.77014407 |
110 | MP0001853_heart_inflammation | 0.76826842 |
111 | MP0000313_abnormal_cell_death | 0.76412149 |
112 | MP0004087_abnormal_muscle_fiber | 0.76046386 |
113 | MP0001915_intracranial_hemorrhage | 0.75841708 |
114 | MP0001666_abnormal_nutrient_absorption | 0.75708935 |
115 | MP0001533_abnormal_skeleton_physiology | 0.75623576 |
116 | MP0002086_abnormal_extraembryonic_tissu | 0.74851216 |
117 | MP0000350_abnormal_cell_proliferation | 0.74430864 |
118 | MP0003448_altered_tumor_morphology | 0.72778521 |
119 | MP0002970_abnormal_white_adipose | 0.72417192 |
120 | MP0002118_abnormal_lipid_homeostasis | 0.72272056 |
121 | MP0000490_abnormal_crypts_of | 0.72189025 |
122 | MP0005319_abnormal_enzyme/_coenzyme | 0.71880497 |
123 | MP0008770_decreased_survivor_rate | 0.71838889 |
124 | MP0002089_abnormal_postnatal_growth/wei | 0.71713700 |
125 | MP0000003_abnormal_adipose_tissue | 0.70902593 |
126 | MP0002009_preneoplasia | 0.70878931 |
127 | MP0002933_joint_inflammation | 0.69477881 |
128 | MP0001663_abnormal_digestive_system | 0.64167503 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperacusis (HP:0010780) | 3.29400207 |
2 | Recurrent abscess formation (HP:0002722) | 3.15919897 |
3 | Papilloma (HP:0012740) | 3.12239601 |
4 | Verrucae (HP:0200043) | 3.12239601 |
5 | Recurrent viral infections (HP:0004429) | 3.08756151 |
6 | Cerebral aneurysm (HP:0004944) | 3.04480458 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.02938429 |
8 | Cellulitis (HP:0100658) | 3.01988715 |
9 | Abnormality of macrophages (HP:0004311) | 2.91731530 |
10 | Abnormality of the fingertips (HP:0001211) | 2.91442303 |
11 | Nasal polyposis (HP:0100582) | 2.90098567 |
12 | Colitis (HP:0002583) | 2.87602508 |
13 | Gastrointestinal inflammation (HP:0004386) | 2.76881939 |
14 | T lymphocytopenia (HP:0005403) | 2.76291168 |
15 | Chronic otitis media (HP:0000389) | 2.72008610 |
16 | Broad face (HP:0000283) | 2.70574191 |
17 | Obstructive lung disease (HP:0006536) | 2.68612957 |
18 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68612957 |
19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.67456516 |
20 | Abnormality of the nasal mucosa (HP:0000433) | 2.66938521 |
21 | Recurrent fungal infections (HP:0002841) | 2.66294000 |
22 | Inflammation of the large intestine (HP:0002037) | 2.63653199 |
23 | Deep venous thrombosis (HP:0002625) | 2.61602522 |
24 | Macroorchidism (HP:0000053) | 2.56934505 |
25 | Abnormality of T cell number (HP:0011839) | 2.56683358 |
26 | Gastrointestinal stroma tumor (HP:0100723) | 2.49876634 |
27 | Autoimmune thrombocytopenia (HP:0001973) | 2.43393710 |
28 | Recurrent bronchitis (HP:0002837) | 2.41095828 |
29 | Increased density of long bones (HP:0006392) | 2.40205557 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 2.39762829 |
31 | Panhypogammaglobulinemia (HP:0003139) | 2.37574303 |
32 | Obstructive sleep apnea (HP:0002870) | 2.36629278 |
33 | Eczematoid dermatitis (HP:0000976) | 2.36569121 |
34 | Distal lower limb amyotrophy (HP:0008944) | 2.35648316 |
35 | Dysmetric saccades (HP:0000641) | 2.35150232 |
36 | Spontaneous hematomas (HP:0007420) | 2.30574083 |
37 | Hemorrhage of the eye (HP:0011885) | 2.28586968 |
38 | Myositis (HP:0100614) | 2.26360041 |
39 | Gingivitis (HP:0000230) | 2.24169404 |
40 | Gastrointestinal infarctions (HP:0005244) | 2.18999839 |
41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18386046 |
42 | Upper limb amyotrophy (HP:0009129) | 2.18041270 |
43 | Distal upper limb amyotrophy (HP:0007149) | 2.18041270 |
44 | Increased IgE level (HP:0003212) | 2.17476287 |
45 | Abnormal platelet volume (HP:0011876) | 2.16989294 |
46 | Recurrent skin infections (HP:0001581) | 2.16019123 |
47 | Hematochezia (HP:0002573) | 2.15377810 |
48 | Abnormality of the lower motor neuron (HP:0002366) | 2.15274794 |
49 | Abnormality of T cells (HP:0002843) | 2.13014958 |
50 | Slow saccadic eye movements (HP:0000514) | 2.11541610 |
51 | Hand muscle atrophy (HP:0009130) | 2.09348229 |
52 | Myocardial infarction (HP:0001658) | 2.08270573 |
53 | Polygenic inheritance (HP:0010982) | 2.07895722 |
54 | Increased connective tissue (HP:0009025) | 2.06500511 |
55 | Interstitial pulmonary disease (HP:0006530) | 2.06044750 |
56 | Agammaglobulinemia (HP:0004432) | 2.05240799 |
57 | Elfin facies (HP:0004428) | 2.05240241 |
58 | Increased cerebral lipofuscin (HP:0011813) | 2.04360869 |
59 | Frequent falls (HP:0002359) | 2.03915323 |
60 | Flat acetabular roof (HP:0003180) | 2.03759233 |
61 | Osteomyelitis (HP:0002754) | 2.03376997 |
62 | Insomnia (HP:0100785) | 2.02648650 |
63 | Abnormal platelet function (HP:0011869) | 2.02470767 |
64 | Impaired platelet aggregation (HP:0003540) | 2.02470767 |
65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01369505 |
66 | Aneurysm (HP:0002617) | 2.00912725 |
67 | Thoracic kyphosis (HP:0002942) | 2.00765833 |
68 | Ulnar bowing (HP:0003031) | 2.00359915 |
69 | Purpura (HP:0000979) | 1.99814944 |
70 | IgM deficiency (HP:0002850) | 1.98652618 |
71 | Emphysema (HP:0002097) | 1.98505608 |
72 | Vasculitis (HP:0002633) | 1.97911373 |
73 | Subacute progressive viral hepatitis (HP:0006572) | 1.95585654 |
74 | Dysostosis multiplex (HP:0000943) | 1.93979504 |
75 | Increased mean platelet volume (HP:0011877) | 1.93312285 |
76 | Pustule (HP:0200039) | 1.92413142 |
77 | Abnormality of the Achilles tendon (HP:0005109) | 1.91758057 |
78 | Hypertensive crisis (HP:0100735) | 1.91004340 |
79 | Polycythemia (HP:0001901) | 1.90844181 |
80 | Long palpebral fissure (HP:0000637) | 1.90843103 |
81 | Pseudobulbar signs (HP:0002200) | 1.90471151 |
82 | Easy fatigability (HP:0003388) | 1.89535290 |
83 | Chest pain (HP:0100749) | 1.89330800 |
84 | Increased serum ferritin (HP:0003281) | 1.87597686 |
85 | Urticaria (HP:0001025) | 1.87437705 |
86 | Heterotopia (HP:0002282) | 1.87024306 |
87 | Thyroiditis (HP:0100646) | 1.86579059 |
88 | Mitral valve prolapse (HP:0001634) | 1.86487725 |
89 | Petechiae (HP:0000967) | 1.86470363 |
90 | Papilledema (HP:0001085) | 1.85690385 |
91 | Aortic aneurysm (HP:0004942) | 1.85223943 |
92 | Vertebral arch anomaly (HP:0008438) | 1.84882172 |
93 | Vertebral compression fractures (HP:0002953) | 1.84573950 |
94 | Achilles tendon contracture (HP:0001771) | 1.84097955 |
95 | Reticulocytosis (HP:0001923) | 1.83424707 |
96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82304607 |
97 | Distal lower limb muscle weakness (HP:0009053) | 1.81719966 |
98 | Increased CSF protein (HP:0002922) | 1.81152750 |
99 | Renovascular hypertension (HP:0100817) | 1.80404728 |
100 | Resting tremor (HP:0002322) | 1.80086007 |
101 | Disproportionate tall stature (HP:0001519) | 1.79733697 |
102 | Abnormality of oral frenula (HP:0000190) | 1.79645075 |
103 | Enlarged penis (HP:0000040) | 1.78961131 |
104 | Lymphangioma (HP:0100764) | 1.78869596 |
105 | Deep palmar crease (HP:0006191) | 1.78831184 |
106 | Meningitis (HP:0001287) | 1.78788061 |
107 | B lymphocytopenia (HP:0010976) | 1.78740183 |
108 | Abnormality of B cell number (HP:0010975) | 1.78740183 |
109 | Mitral stenosis (HP:0001718) | 1.78608977 |
110 | Orchitis (HP:0100796) | 1.78459004 |
111 | Fatigue (HP:0012378) | 1.78321386 |
112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77484331 |
113 | Complement deficiency (HP:0004431) | 1.77074232 |
114 | Cholecystitis (HP:0001082) | 1.76219019 |
115 | Abnormal gallbladder physiology (HP:0012438) | 1.76219019 |
116 | Lymphopenia (HP:0001888) | 1.75953106 |
117 | Arterial thrombosis (HP:0004420) | 1.74420990 |
118 | Metaphyseal cupping (HP:0003021) | 1.73944483 |
119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73472854 |
120 | Pointed chin (HP:0000307) | 1.72839100 |
121 | Hypertriglyceridemia (HP:0002155) | 1.71922760 |
122 | Granulocytopenia (HP:0001913) | 1.70365196 |
123 | Prolonged bleeding time (HP:0003010) | 1.69578478 |
124 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69509098 |
125 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69509098 |
126 | Loss of speech (HP:0002371) | 1.69317336 |
127 | Gingival bleeding (HP:0000225) | 1.68662698 |
128 | Spastic diplegia (HP:0001264) | 1.68369497 |
129 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68319839 |
130 | Encephalitis (HP:0002383) | 1.67228380 |
131 | Asymmetric septal hypertrophy (HP:0001670) | 1.66285193 |
132 | Skin ulcer (HP:0200042) | 1.65294782 |
133 | Xanthomatosis (HP:0000991) | 1.64744144 |
134 | Annular pancreas (HP:0001734) | 1.64407534 |
135 | Seborrheic dermatitis (HP:0001051) | 1.64295969 |
136 | Abnormality of T cell physiology (HP:0011840) | 1.64080864 |
137 | Basal cell carcinoma (HP:0002671) | 1.63967467 |
138 | Ankyloglossia (HP:0010296) | 1.63303560 |
139 | High pitched voice (HP:0001620) | 1.63003248 |
140 | Cutaneous melanoma (HP:0012056) | 1.62680592 |
141 | Viral hepatitis (HP:0006562) | 1.62562427 |
142 | Global brain atrophy (HP:0002283) | 1.61868265 |
143 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.61770520 |
144 | Striae distensae (HP:0001065) | 1.60974834 |
145 | Combined immunodeficiency (HP:0005387) | 1.60203832 |
146 | Thin bony cortex (HP:0002753) | 1.59460047 |
147 | Hemiplegia (HP:0002301) | 1.58814102 |
148 | Thrombocytosis (HP:0001894) | 1.58501394 |
149 | Dilatation of the ascending aorta (HP:0005111) | 1.57392157 |
150 | Abnormality of the thoracic spine (HP:0100711) | 1.57040446 |
151 | Bicuspid aortic valve (HP:0001647) | 1.56502310 |
152 | Epistaxis (HP:0000421) | 1.55400560 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.45027307 |
2 | EEF2K | 4.40563414 |
3 | PRPF4B | 4.01195453 |
4 | MAP3K10 | 3.95873403 |
5 | PKN2 | 3.90538746 |
6 | SMG1 | 3.34233777 |
7 | MAP4K1 | 3.25402325 |
8 | ERN1 | 2.34854455 |
9 | IRAK3 | 2.33777049 |
10 | CDK12 | 2.28575740 |
11 | GRK6 | 2.05601728 |
12 | PTK6 | 1.96997979 |
13 | FGFR4 | 1.76764422 |
14 | RIPK1 | 1.75845720 |
15 | SIK2 | 1.74893508 |
16 | STK10 | 1.71945641 |
17 | TTN | 1.58152886 |
18 | IRAK4 | 1.54580965 |
19 | TYK2 | 1.54454415 |
20 | ALK | 1.53578853 |
21 | EPHB1 | 1.51397405 |
22 | LRRK2 | 1.48669150 |
23 | MAP3K14 | 1.44689280 |
24 | TAOK2 | 1.44643923 |
25 | ICK | 1.40728005 |
26 | SIK1 | 1.40604044 |
27 | JAK3 | 1.35107749 |
28 | MAP3K11 | 1.34582992 |
29 | NME2 | 1.31399942 |
30 | JAK1 | 1.29948080 |
31 | ZAP70 | 1.28698106 |
32 | FGFR3 | 1.27617844 |
33 | TESK2 | 1.23886253 |
34 | MAP3K7 | 1.22556346 |
35 | MAP3K3 | 1.22242457 |
36 | SCYL2 | 1.21897061 |
37 | TAOK1 | 1.19313211 |
38 | PRKCH | 1.17103470 |
39 | ITK | 1.08077551 |
40 | CAMK1G | 1.06753050 |
41 | PDGFRA | 1.06123156 |
42 | HCK | 1.04300139 |
43 | JAK2 | 1.03141865 |
44 | KSR2 | 1.01778884 |
45 | BMX | 1.01405650 |
46 | CAMK1D | 0.99952334 |
47 | SIK3 | 0.99616320 |
48 | RET | 0.99535228 |
49 | TYRO3 | 0.97915471 |
50 | BTK | 0.97910529 |
51 | TAOK3 | 0.96517525 |
52 | CSK | 0.94894963 |
53 | SYK | 0.94086748 |
54 | FES | 0.93786346 |
55 | CSF1R | 0.92957094 |
56 | CDC42BPA | 0.92636782 |
57 | CDK4 | 0.92197474 |
58 | NEK2 | 0.90593788 |
59 | CDK6 | 0.88395775 |
60 | TBK1 | 0.86792823 |
61 | MAP2K3 | 0.86122696 |
62 | PRKD3 | 0.85663202 |
63 | DMPK | 0.85622336 |
64 | CAMKK1 | 0.85600855 |
65 | MTOR | 0.85271992 |
66 | IRAK2 | 0.84772452 |
67 | FLT3 | 0.82314355 |
68 | PDK1 | 0.81795931 |
69 | EPHA2 | 0.77879240 |
70 | MAPK11 | 0.77300823 |
71 | SGK3 | 0.74962717 |
72 | PDGFRB | 0.74071957 |
73 | TGFBR2 | 0.72350650 |
74 | RIPK4 | 0.72009661 |
75 | MAP3K13 | 0.70453243 |
76 | HIPK2 | 0.69840773 |
77 | RPS6KB2 | 0.67154340 |
78 | ARAF | 0.66023979 |
79 | LCK | 0.64916383 |
80 | MAP3K8 | 0.64112264 |
81 | MAP2K2 | 0.62583882 |
82 | MST1R | 0.62009324 |
83 | CLK1 | 0.61421449 |
84 | MAP3K9 | 0.59844165 |
85 | PIM1 | 0.58664170 |
86 | BLK | 0.58478675 |
87 | MARK2 | 0.55543987 |
88 | PAK4 | 0.55159354 |
89 | TNK2 | 0.54827664 |
90 | RPS6KA2 | 0.53756122 |
91 | IKBKE | 0.52728267 |
92 | FGFR2 | 0.52692997 |
93 | STK4 | 0.52456888 |
94 | PDPK1 | 0.51973387 |
95 | TESK1 | 0.51644438 |
96 | CDK7 | 0.51552327 |
97 | MARK3 | 0.51209476 |
98 | MAP3K2 | 0.50213059 |
99 | LYN | 0.50032445 |
100 | DAPK2 | 0.48889877 |
101 | BRAF | 0.46212466 |
102 | FGR | 0.45848010 |
103 | PAK2 | 0.44854453 |
104 | PRKD1 | 0.43954367 |
105 | MAP3K1 | 0.43594049 |
106 | DYRK1B | 0.42966445 |
107 | BRD4 | 0.42822850 |
108 | STK11 | 0.42064762 |
109 | KIT | 0.40491898 |
110 | PRKD2 | 0.40240905 |
111 | EGFR | 0.40140309 |
112 | MAP3K6 | 0.39919651 |
113 | LMTK2 | 0.39160234 |
114 | MAPKAPK3 | 0.38660035 |
115 | MAPKAPK2 | 0.38352576 |
116 | MAPK12 | 0.38227980 |
117 | RPS6KA1 | 0.37382428 |
118 | IKBKB | 0.37369296 |
119 | CDK9 | 0.36671488 |
120 | RPS6KA6 | 0.36602332 |
121 | MAPK4 | 0.35775236 |
122 | RPS6KL1 | 0.35316641 |
123 | RPS6KC1 | 0.35316641 |
124 | MAPK7 | 0.35166993 |
125 | PTK2 | 0.34465250 |
126 | CHUK | 0.34259468 |
127 | MATK | 0.33338287 |
128 | PASK | 0.33246265 |
129 | TXK | 0.33155171 |
130 | FYN | 0.32602408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.72604863 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.36909947 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29445868 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.23559212 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15945279 |
6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.87507100 |
7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67196075 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63984817 |
9 | Lysine degradation_Homo sapiens_hsa00310 | 1.60970145 |
10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.57285350 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55409608 |
12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53957803 |
13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50734288 |
14 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.47196628 |
15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.43583702 |
16 | Insulin resistance_Homo sapiens_hsa04931 | 1.39878104 |
17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37681995 |
18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.35135558 |
19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27434820 |
20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.27030859 |
21 | Bladder cancer_Homo sapiens_hsa05219 | 1.25470217 |
22 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.25202007 |
23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25163283 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24475536 |
25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24012043 |
26 | Glioma_Homo sapiens_hsa05214 | 1.21162639 |
27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17935235 |
28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16673444 |
29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16268372 |
30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15384425 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14125413 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11676098 |
33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09404749 |
34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09056245 |
35 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08877268 |
36 | Platelet activation_Homo sapiens_hsa04611 | 1.08388474 |
37 | Allograft rejection_Homo sapiens_hsa05330 | 1.08328285 |
38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07524672 |
39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07121595 |
40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06282267 |
41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05649905 |
42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02624305 |
43 | Bile secretion_Homo sapiens_hsa04976 | 1.02026168 |
44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01463668 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01133099 |
46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01031448 |
47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00395382 |
48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00160794 |
49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.98940256 |
50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95951014 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95518509 |
52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95034504 |
53 | Measles_Homo sapiens_hsa05162 | 0.94480330 |
54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94312903 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93780025 |
56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93154795 |
57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91610642 |
58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90493769 |
59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89720376 |
60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89331128 |
61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89253797 |
62 | Prion diseases_Homo sapiens_hsa05020 | 0.88419976 |
63 | Prostate cancer_Homo sapiens_hsa05215 | 0.88085713 |
64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87519481 |
65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86350565 |
66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86273620 |
67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86216879 |
68 | ABC transporters_Homo sapiens_hsa02010 | 0.84868661 |
69 | Hepatitis B_Homo sapiens_hsa05161 | 0.84827599 |
70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84645937 |
71 | Malaria_Homo sapiens_hsa05144 | 0.84632894 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83082896 |
73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82449873 |
74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81456326 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79957839 |
76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77814298 |
77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77327715 |
78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76591819 |
79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75989329 |
80 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75510315 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75484243 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74906189 |
83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74702210 |
84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73122495 |
85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73077976 |
86 | Apoptosis_Homo sapiens_hsa04210 | 0.72748902 |
87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72427791 |
88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71854443 |
89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71751861 |
90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70698758 |
91 | Salmonella infection_Homo sapiens_hsa05132 | 0.70373879 |
92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69529021 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69257676 |
94 | Tuberculosis_Homo sapiens_hsa05152 | 0.68457353 |
95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68308659 |
96 | Lysosome_Homo sapiens_hsa04142 | 0.67711880 |
97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67633323 |
98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64496616 |
99 | Influenza A_Homo sapiens_hsa05164 | 0.64421308 |
100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63773214 |
101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63550019 |
102 | Focal adhesion_Homo sapiens_hsa04510 | 0.63472909 |
103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63263331 |
104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62845639 |
105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61963012 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.61936664 |
107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61192734 |
108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61087240 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60489781 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59214294 |
111 | Shigellosis_Homo sapiens_hsa05131 | 0.58016289 |
112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56957024 |
113 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56878948 |
114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56535653 |
115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56471451 |
116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56114342 |
117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55600575 |
118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55232379 |
119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55150968 |
120 | Pertussis_Homo sapiens_hsa05133 | 0.54943765 |
121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54834549 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.54611771 |
123 | Amoebiasis_Homo sapiens_hsa05146 | 0.54079555 |
124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54026746 |
125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52762560 |
126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52483694 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51683308 |
128 | Hepatitis C_Homo sapiens_hsa05160 | 0.49615284 |
129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49420364 |
130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47894741 |